Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumor necrosis factor alpha blockers and the induction of anti-DNA autoantibodies.

Literature DB >> 11083257

Tumor necrosis factor alpha blockers and the induction of anti-DNA autoantibodies.

D S Pisetsky.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2000 PMID： 11083257 DOI： 10.1002/1529-0131(200011)43:11<2381::AID-ANR1>3.0.CO;2-M

Source DB: PubMed Journal: Arthritis Rheum ISSN： 0004-3591

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

1. Etanercept and infliximab induce the same serological autoimmune modifications in patients with rheumatoid arthritis.

Authors: Marco Fusconi; Antonio Vannini; Anna Chiara Dall'Aglio; Georgios Pappas; Francesco B Bianchi; Daniela Zauli
Journal: Rheumatol Int Date: 2007-06-13 Impact factor: 2.631

Review 2. Safety of etanercept in psoriasis: a critical review.

Authors: Jose L Sánchez Carazo; Laura Mahiques Santos; Vicente Oliver Martinez
Journal: Drug Saf Date: 2006 Impact factor: 5.606

3. Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment.

Authors: Paola Caramaschi; Domenico Biasi; Elisabetta Tonolli; Sara Pieropan; Nicola Martinelli; Antonio Carletto; Alessandro Volpe; Lisa Maria Bambara
Journal: Rheumatol Int Date: 2005-02-23 Impact factor: 2.631

4. Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity.

Authors: Paola Caramaschi; Domenico Biasi; Marco Colombatti; Sara Pieropan; Nicola Martinelli; Antonio Carletto; Alessandro Volpe; Luisa Maria Pacor; Lisa Maria Bambara
Journal: Rheumatol Int Date: 2004-12-31 Impact factor: 2.631

5. Increased CD69+CCR7+ circulating activated T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials.

Authors: Majid Zeidi; Kristen L Chen; Jay Patel; Krisha Desai; Hee Joo Kim; Srita Chakka; Rachel Lim; Victoria P Werth
Journal: Lupus Date: 2022-03-08 Impact factor: 2.911

10. Importance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritis.

Authors: Frédéric Reynier; Fabien Petit; Malick Paye; Fanny Turrel-Davin; Pierre-Emmanuel Imbert; Arnaud Hot; Bruno Mougin; Pierre Miossec
Journal: PLoS One Date: 2011-10-17 Impact factor: 3.240

Tumor necrosis factor alpha blockers and the induction of anti-DNA autoantibodies.

1. Etanercept and infliximab induce the same serological autoimmune modifications in patients with rheumatoid arthritis.

Review 2. Safety of etanercept in psoriasis: a critical review.

3. Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment.

4. Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity.

5. Increased CD69+CCR7+ circulating activated T cells and STAT3 expression in cutaneous lupus erythematosus patients recalcitrant to antimalarials.

6. Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.

Review 7. Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis.

8. Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis.

9. Serious liver disease induced by infliximab.

10. Importance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritis.